Denmark predicts new EU requirements following Dicillin scandal

The contamination of an antibiotic that infected Danish patients with multiresistant bacteria is such an unusual case it could lead to wide-reaching consequences, says the Danish Medicines Agency. 
Photo: Lægemiddelstyrelsen/pr
Photo: Lægemiddelstyrelsen/pr
by ulrich quistgaard, translated by daniel pedersen

The Dicillin scandal currently evolving in Denmark could lead to new EU requirements for drug making, says the Danish Medicines Agency.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading